Xometry, Inc. Class A Common Stock
XMTRXometry, Inc. Class A (XMTR) is a manufacturing marketplace that connects customers with a network of suppliers for custom manufacturing services, including CNC machining, 3D printing, and sheet metal fabrication. Founded to streamline the sourcing and production process, Xometry offers on-demand manufacturing solutions through an online platform, enabling rapid quotes and scalable production for a variety of industries.
Company News
Xometry, Inc. (NASDAQ: XMTR) announced the pricing of an underwritten public offering of 2,647,059 shares of Class A common stock at $85.00 per share, generating approximately $225.0 million in gross proceeds. The offering is expected to close on June 3, 2026, with net proceeds intended for working capital and general corporate purposes. J.P. Mor...
Xometry announced it will present at two major investor conferences in May and June 2026, including a fireside chat at the J.P. Morgan Global Technology Conference on May 19 and a presentation at the William Blair Growth Stock Conference on June 4. The company also announced it will release its Q1 2026 financial results on May 7, 2026.
Xometry President Sanjeev Singh Sahni sold 26,190 shares worth $1.71 million in a planned transaction tied to RSU vesting and tax withholding obligations. Despite the insider sale, Xometry's stock has significantly outperformed the S&P 500 with an 87.51% one-year gain. The company reported strong Q3 results with record revenue of $180.7 million (...
Eventide Asset Management sold 114,922 shares of Mirum Pharmaceuticals in Q3, but the position's value increased by approximately $50.70 million to $184.92 million due to the stock's 89% surge over the past year. The share reduction appears to be portfolio management rather than a loss of confidence, as Mirum posted strong Q3 revenue growth of 47...
The article argues that the key to becoming a better investor in 2026 is improving the ability to hold stocks through market volatility. The author recommends prioritizing investments in companies you genuinely love and care about, rather than solely focusing on highest upside potential, as emotional attachment makes it easier to resist selling d...
